Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

59 57 32 59 77 13 11 20 37 22 37 55 22 12

Research, Review articles and Editorials

1 0 5 42 32 12 10 14 27 21 33 44 21 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

48 57 27 17 45 1 1 6 10 1 4 11 1 2

Conference proceedings

0 0 0 0 0 0 35 51 125 100 191 0 125 177

Citations received as per Google Scholar, other indexing platforms and portals

98 160 172 269 223 172 219 195 170 116 60 36 26 58
Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

Non-structural proteases as a target of dengue virus

Transcriptome analysis and connectivity mapping of cissampelos pareira l. provides molecular links of esr1 modulation to viral inhibition

In vitro antiviral activity of ?-mangostin against dengue virus serotype-2 (denv-2)

Emetine, a potent alkaloid for the treatment of sars-cov-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies

Identification of novel antiviral compounds targeting entry of hantaviruses

Traditional use of cissampelos pareira l. for hormone disorder and fever provides molecular links of esr1 modulation to viral inhibition

Zika virus (zikv) infection: a review

Emetine is not ipecac: considerations for its use as treatment for sars-cov2

Incompatibility of chemical protein synthesis inhibitors with accurate measurement of extended protein degradation rates

Betulinic acid exhibits antiviral effects against dengue virus infection

Antiviral activity of st081006 against the dengue virus

Antiviral activity of the fda-approved drug candesartan cilexetil against zika virus infection

Resveratrol afects zika virus replication in vitro

Emetine inhibits zika and ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry

Therapeutic drugs for sars-cov-2 treatment: current state and perspective

High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses

Discovery of synergistic and antagonistic drug combinations against sars-cov-2 in vitro

Assessment on utilization of health management information system and associate factors at public health centers addis ababa city administration, ethiopia

Antiretroviral treatment adherence and determinant factors among adult people infected with human immunodeficiency virus in eastern tigray general hospitals, northern ethiopia, 2019

Adherence to combined antiretroviral therapy and associated factors among people living with hiv attending nekemte specialized hospital, oromia, ethiopia: a cross-sectional study

Top